spacer
home > ebr > spring 2002 > a record-breaking us$27 billion of biotech deals supports strong pharma m&a activity in 2001
PUBLICATIONS
European Biopharmaceutical Review

A Record-Breaking US$27 Billion of Biotech Deals Supports Strong Pharma M&A Activity in 2001

The value of pharmaceutical mergers and acquisitions (M&A) in 2001 almost doubled to US$61 billion from US$34 billion in 2000 (excluding the US$76 billion formation that year of GlaxoSmithKline), bucking the significant downward trend witnessed in most other sectors. The number of deals remained stable at 334 in 2001, compared with 341 in 2000. In a period where most industries have experienced at least a 25 per cent downturn in M&A activity, the pharmaceutical sector has maintained its deal-making momentum. The aggregate value of deals is down because 2001 witnessed no mega-mergers to rival the prior year combination of Glaxo Wellcome and SmithKline Beecham. But with Amgen's US$17 billion bid for Immunex, plus a further US$10 billion of biotech deals in 2001, the foundations are being laid for a Big Biotech sector that will increasingly compete with Big Pharma.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Neal Ransome, Partner at PricewaterhouseCoopers Corporate Finance

Neal Ransome is European leader of PricewaterhouseCoopers' Pharmaceuticals and Healthcare Corporate Finance team. He has over 10 years' experience of corporate finance transactions, and has been focusing on the pharma and health care sectors since 1997. Neal's clients in the sector have included large pharmacos such as GlaxoSmithKline and Aventis, emerging companies such as Powderject and a wide range of smaller clients in the health care and biotech sectors.
Neal has also acted for a large number of private equity clients in the sector, including 3i, Warburg Pincus and Mercury. The European team which he leads comprises approximately 20 professional staff, located in all key financial centres, and combines corporate finance experts with recruits from the industry.

spacer
Neal Ransome
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Non-invasive SONOFLOW | Flow Sensors and SONOFLOW | C Software: The user-friendly smart sensoring package for application in laboratory 4.0, R&D, and single-use production environments

With the influence of digitization and increasing needs for process monitoring, laboratory, R&D, and single-use production environments are changing rapidly. Networked laboratory devices with smart functions, automation concepts, and efficient interface solutions have altered laboratory workflows and stand for the new era of Lab 4.0. Therefore, a rising tide of the continuous availability of data requires an easy data handling and secure data logging.
More info >>

White Papers
 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement